Chimeral agglomerates of microparticles for the administration of caffeine nasal powders

Journal of Drug Delivery Science and Technology

Volumn 14, Issue 6, 2004, Pages 449-454

  Russo, P ^a   Buttini, F ^a   Sonvico, F ^a   Bettini, R ^a   Massimo, G ^a   Sacchetti, C ^a   Colombo, P ^a   Santi, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Caffeine; Chimeral agglomerates; Insufflators; Nasal powders; Spray drying

Indexed keywords

CAFFEINE; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; LIPOID S45; MACROGOL 6000; MANNITOL; METHOCEL E3; PHOSPHATIDYLCHOLINE;

AERATION; ARTICLE; CHIMERA; DRUG SOLUBILITY; MORPHOLOGY; PARTICLE SIZE; SPRAY DRYING;

EID: 9944231960     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-2247(04)50083-7     Document Type: Article

References (30)

1. ANWAR A. HUSSAIN - Intranasal drug delivery. - Adv. Drug Del. Rev., 29, 39-49, 1998.
2. JONES N. - The nose and paranasal sinuses physiology and anatomy. - Adv. Drug Deliv. Rev., 51, 5-19, 2001.
3. KHANVILKAR K., DONOVAN M.D., FLANAGAN D.R. - Drug transfer through mucus. - Adv. Drug Deliv. Rev., 48, 173-93, 2001.
4. ILLUM L. - Nasal drug delivery: possibilities, problems and solutions. - J. Controlled Release, 87, 187, 2003.
5. ILLUM L. - Nasal drug delivery: new developments and strategies. - DDT, 7, 23, 2002.
6. ARORA P., SHARMA S., GARG S. - Permeability issues in nasal drug delivery. - Drug. Discover. Today, 7, 967-75, 2002.
7. MINN A., LECLERC S., HEYDEL J.M., MINN A.L, DENIZCOT C., CATTARELLI M., NETTER P., GRADINARU D. - Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier. - J. Drug Target., 10, 285-96, 2002.
8. ILLUM L. - Transport of drugs from the nasal cavity to the central nervous system. - Eur. J. Pharm. Sci., 11, 1-18 2000.
9. MARTTIN E., SCHIPPER N.G.M., VERHOEF J.C., MERKUS F.W.H.M. - Nasal mucociliary clearance as a factor in nasal drug delivery. - Adv. Drug Del. Rev., 29, 13, 1998.
10. MARTTIN E., ROMEIJN S.G., VERHOEF J.C., MERKUS F.W. - Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbits. - J. Pharm. Sci., 86, 802-7, 1997.
11. THORSSON L., BORGA O., EDSBACKER S. - Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder. - Br. J. Clin. Pharmacol., 47, 619-24, 1999.
12. CALLENS C., REMON J.P. - Evaluation of starch-maltodextrin-Carbopol 974 P mixtures for the nasal delivery of insulin in rabbits. - J. Control. Release., 66, 215-20, 2000.
13. KIVISAARI E., BAKER R.C., PRICE M.J. - Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis. - Clin. Exp. Allergy, 31, 855-63, 2001.
14. ISHIKAWA F., KATSURA M., TAMAI I., TSUJI A. - Improved nasal bioavailability of elcatonin by insoluble powder formulation. - Int. J. Pharm., 224, 105-114, 2001.
15. GARCIA-ARIETA A., TORRADO-SANTIAGO S., GOJA L., TORRADO J.J. - Spray-dried powders as nasal absorption enhancers of cyanocobalamin. - Biol. Pharm. Bull., 24, 1411-6, 2001.
16. TESHIMA D., YAMAUCHI A., MAKINO K., KATAOKA Y., ARITA Y., NAWATA H., OISHI R. - Nasal glucagone delivery using microcrystalline cellulose in healthy volunteers. - Int. J. Pharm., 233, 61-6, 2002.
17. UGKOWE M.I., VERBEKE N., KINGET R. - The biopharmaceutical aspects of nasal mucoadhesive drug delivery. - J. Pharm. Pharmacol., 53, 3-21, 2001.
18. DONDETI P., ZIA H., NEEDHAM T.E. - Bioadhesive and formulation parameters affecting nasal absorption. - Int. J. Pharm., 127, 115-133, 1996.
19. CALLENS C., CEULEMANS J., LUDWIG A., FOREMAN P., REMON J.P. - Rheological study on mucoadhesive of some nasal powder formulations. - Eur. J. Pharm. Biopharm., 55, 323-8, 2003
20. CALLENS C., PRINGELS E., REMON J.P. - Influence of multiple nasal administrations of bioadhesive powders on the insulin bioavailability. - Int. J. Pharm., 250, 415-422, 2003.
21. UGKOWE M.I., EXAUD S., VAN DEN MOOTER G., VERBEKE N., KINGET R. - Biovailability of apomorphinefollowing intranasal administration of mucoadhesive drug delivery sistems in rabbits. Eur. J. Pharm. Sci., 9, 213-9, 1999.
22. BELL J.H. - Composition for treating airway disease. - US Patent 4,161,516, 1979.
23. WETTERLIN K. - Turbuhaler: a new powder inhaler for administration of drugs to the airways. - Pharm. Res., 5, 506, 1988.
24. YANG T.T., KENYON D. - Use of an agglomerate formulation in a new multidose dry powder inhaler. - In: Respiratory Drug Delivery VII, Dalby R.N., Byron P.R., Farr S.J., Peart J. Eds, Serentec Press, 2000, pp. 503-505.
25. ILLUM L., JORGENSEN H., BISGAARD H., KROGSGAARD O., ROSSING N. - Bioadhesive microspheres as a potential nasal drug delivery system. - Int. J. Pharm., 39, 189, 1987.
26. SACCHETTI C., ARTUSI M., SANTI P., COLOMBO P. - Caffeine microparticles for nasal administration obtained by spray drying. - Int. J. Pharm., 242, 335, 2002.
27. CHEN J.F., XU K., PETZER J.P., STAAL R., XU Y.H., BEILSTEIN M., SONSALLA P.K., CASTAGNOLI K., CASTAGNOLI N.Jr., SCHWARZSCHILD M.A. - Neuroprotection by caffeine and A2A adenosine receptors inactivation in a model of Parkinson's disease. - J. Neurosci., 21, 10, RC143, 2001.
28. CARR, R.L. - Evaluating flow properties of solids. -Chem Eng. 72, 163-168, 1965.
29. HIRAMATSU Y., OKA Y. - Determination of the tensile strength of rock by a compression test of an irregular test piece. - Int. J. Rock Mech. Min. Sci., 3, 89, 1966.
30. BEHL C.R., PIMPLASKAR H.K., SILENO A.P., DEMEIRELES J., ROMEO V.D. - Effects of physicochemical properties and other factors on systemic nasal drug delivery. - Adv. Drug Del. Rev., 29, 89, 1998.